A murine dopamine neuron-specific cDNA library and microarray: Increased COX1 expression during methamphetamine neurotoxicity

Neurobiology of Disease

Volumn 8, Issue 5, 2001, Pages 822-833

  Barrett, Tanya ^a   Xie, Tao ^d   Piao, Yulan ^b   Dillon Carter, Ora ^c   Kargul, George J ^b   Lim, Meng K ^b   Chrest, Francis J ^a   Wersto, Robert ^a   Rowley, Daniel L ^a   Juhaszova, Magdalena ^a   Zhou, Li ^a   Vawter, Marquis P ^c   Becker, Kevin G ^a   Cheadle, Christopher ^a   Wood III, William H ^a   McCann, Una D ^d   Freed, William J ^c   Ko, Minoru S ^b   Ricaurte, George A ^d   Donovan, David M ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b Intramural Research Program National Institute on Aging 5600 Nathan Shock Drive   (Australia)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cDNA library; cDNA microarray; Development; Dopamine; Gene expression profile; Methamphetamine

Indexed keywords

COMPLEMENTARY DNA; DOPAMINE; METHAMPHETAMINE;

ANIMAL CELL; ARTICLE; DNA SEQUENCE; DOPAMINERGIC NERVE CELL; DRUG ABUSE; EMBRYO; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION; MESENCEPHALON; MOUSE; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

EID: 0035173005     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2001.0423     Document Type: Article

References (63)

1. A systematic molecular genetic approach to study mammalian germline development
2. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: Pharmacological profile of protective and nonprotective agents
3. Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice
4. Flow cytometric analysis of glucose transport by rat brain cells
5. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs
6. Age-related cognitive deficits mediated by changes in the striatal dopamine system
7. 5′ Flanking sequences of the rat tyrosine hydroxylase gene target accurate tissue-specific, developmental, and transsynaptic expression in transgenic mice
8. Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations
9. Chronic systemic pesticide exposure reproduces features of Parkinson's disease
10. The behavioural and motor consequences of focal lesions of the basal ganglia in man
11. Further studies of the role of hyperthermia in methamphetamine neurotoxicity
12. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in striatum
13. Central administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines
14. Effect of 7-nitroindazole on body temperature and methamphetamine-induced dopamine toxicity
15. Structure and function of cytochrome c oxidase
16. Alpha-phenyl-N-tert-butyl nitrone attenuates methamphetamine-induced depletion of striatal dopamine without altering hyperthermia
17. Network interactions in schizophrenia - Therapeutic implications
18. Time course of brain temperature and caudate/putamen microdialysate levels of amphetamine and dopamine in rats after multiple doses of d-amphetamine
19. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular stress
20. Cocaine reward and MPTP toxicity: Alteration by regional variant dopamine transporter overexpression
21. Myelin acquisition in the central nervous system of the mouse revealed by an MBP-lacZ transgene
22. A single dose model of methamphetamine-induced neurotoxicity in rats: Effects on neostratal monoamines and glial fibrillary acidic protein
23. Ontogeny of dopamine transporter mRNA expression in the rat brain
24. Role of dopamine transporter in methamphetamine-induced neurotoxicity: Evidence from mice lacking the transporter
25. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice
26. Mice, microarrays, and the genetic diversity of the brain
27. Neurochemical mechanisms of toxicity
28. Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity
29. Ontogeny of vesicular monoamine transoreter mRNAs VMAT1 and VMAT2. I. The Developing rat central nervous system
30. Nicotinamide attenuates methamphetamine-induced striatal dopamine depletion in rats
31. The transcriptional program in the response of human fibroblasts to serum
32. Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice
33. Large-scale cDNA analysis reveals phased gene expression patterns during preimplantation mouse development
34. Genome-wide mapping of unselected transcripts from extraembryonic tissue of 7.5-day mouse embryos reveals enrichment in the t-complex and under-representation on the X chromosome
35. Neurobiology of addiction: Toward the development of new therapies
36. Methamphetamine-induced hyperthermia in mice: Examination of dopamine depletion and heat-shock protein induction
37. Gene-expression profile of the ageing brain in mice
38. Evidence for and mechanism of action of neurotoxicity of amphetamine related compounds
39. 11C]WIN-35,428
40. Developmentally regulated rat brain mRNAs: Molecular and anatomical characterization
41. Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity
42. Human cortical neuronal cell line (HCN-1): Further in vitro characterization and suitability for brain transplantation
43. Lasting effects of (±)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: Neurochemical observations
44. Arousal systems and attentional processes
45. Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis?
46. Regional and strain-specific gene expression mapping in the adult mouse brain
47. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis
48. Immunohistochemistry and immunocytochemistry of neural cell types in vitro and in situ
49. 4.5 kb of the rat tyrosine hydroxylase 5′ flanking sequence directs tissue specific expression during development and contains consensus sites for multiple transcription factors
50. Role of dopamine in the neurotoxic effects of methamphetamine
51. Neurotoxicity of methamphetamine and related drugs
52. Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum
53. Standardized methods to bioassay neurotrophic factors for dopaminergic neurons
54. Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray
55. 11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations
56. Microglial activation precedes acute neurodegeneration in sandhoff disease and is suppressed by bone marrow transplantation
57. Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes
58. Mitochondrial involvement in schizophrenia and other functional psychoses
59. Potential new insights into the molecular mechanisms of methamphetamine-induced neurodegeneration
60. Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: Implications for methamphetamine-induced dopaminergic neurotoxicity
61. The effects of methamphetamine on the production of free radicals and oxidative stress
62. Isolation of novel mouse genes differentially expressed in brain using cDNA microarray
63. Ibogaine blocked methamphetamine-induced hyperthermia and induction of heat shock protein in mice